| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 30.59▼ | 30.61▼ | 30.58▼ | 29.79▲ | 28.68▲ |
| MA10 | 30.58▼ | 30.56▲ | 30.27▲ | 29.42▲ | 27.13▲ |
| MA20 | 30.58▼ | 30.19▲ | 29.84▲ | 28.55▲ | 24.41▲ |
| MA50 | 30.58▼ | 29.69▲ | 29.64▲ | 26.21▲ | 23.98▲ |
| MA100 | 30.30▲ | 29.53▲ | 29.33▲ | 23.99▲ | 21.55▲ |
| MA200 | 29.87▲ | 29.23▲ | 27.52▲ | 24.24▲ | 21.21▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.020▲ | 0.102▲ | 0.019▲ | 0.791▲ |
| RSI | 48.869▼ | 69.202▲ | 67.952▲ | 67.881▲ | 70.426▲ |
| STOCH | 55.636 | 76.522 | 90.981▲ | 67.773 | 83.030▲ |
| WILL %R | -47.727 | -15.837▲ | -10.903▲ | -12.583▲ | -3.771▲ |
| CCI | -77.736 | 49.445 | 76.078 | 161.270▲ | 134.649▲ |
|
Monday, August 24, 2026 05:42 PM
Acadia (ACAD) eyes Phase 2 remlifanserin Alzheimer’s psychosis results by September/October. Learn about the risks and revenue cushion from Daybue/Nuplazid.
|
|
Monday, August 24, 2026 12:01 AM
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms ...
|
|
Wednesday, August 12, 2026 07:18 AM
ACADIA Pharmaceuticals gains attention after stronger quarterly performance and a higher price outlook as its CNS drug strategy remains firmly in focus.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/08/26 | 30.14 | 30.75 | 29.865 | 30.575 | 1,255,628 |
| 24/08/26 | 29.28 | 29.77 | 29.145 | 29.65 | 866,874 |
| 21/08/26 | 29.08 | 29.615 | 28.80 | 29.50 | 1,067,488 |
| 20/08/26 | 30.00 | 30.00 | 28.95 | 29.04 | 1,318,667 |
| 19/08/26 | 30.66 | 30.96 | 30.07 | 30.21 | 2,221,998 |
| 18/08/26 | 29.14 | 30.25 | 29.05 | 30.18 | 2,020,549 |
| 17/08/26 | 28.63 | 29.03 | 28.21 | 29.01 | 1,071,255 |
| 14/08/26 | 28.26 | 28.425 | 27.9004 | 28.24 | 1,032,925 |
| 13/08/26 | 29.75 | 29.75 | 28.36 | 28.38 | 1,414,698 |
| 12/08/26 | 29.18 | 29.84 | 28.83 | 29.45 | 1,409,738 |
|
|
||||
|
|
||||
|
|